# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA691219 | F | Anti-HRV activity against HRV serotype 2 | human rhinovirus type 2 | 3 | organism-based format | Scientific Literature | ||
2. | ALA696229 | F | Antirhinovirus activity was determined by the ability to inhibit the HRV-2 (human rhinovirus type -2) virus by plaque reduction assay in vitro | human rhinovirus type 2 | 2 | organism-based format | Scientific Literature | ||
3. | ALA879718 | F | Antiviral activity determined by ability to inhibit the HRV-2( human rhinovirus type -2) virus by plaque reduction assay in vitro | human rhinovirus type 2 | 23 | organism-based format | Scientific Literature | ||
4. | ALA696230 | F | Antirhinovirus activity was determined by the ability to inhibit the HRV-2( human rhinovirus type -2) virus by plaque reduction assay in vitro; IA is inactive | human rhinovirus type 2 | 2 | organism-based format | Scientific Literature | ||
5. | ALA696043 | F | Antirhinovirus activity was determined by the ability to inhibit the HRV-2 virus growth by 80% | human rhinovirus type 2 | 17 | organism-based format | Scientific Literature | ||
6. | ALA696044 | F | Antirhinovirus activity was determined by the ability to inhibit the HRV-2 virus growth by 80%; ND is no data | human rhinovirus type 2 | 7 | organism-based format | Scientific Literature | ||
7. | ALA696045 | F | Antirhinovirus activity was determined by the ability to inhibit the HRV-2 virus growth by 80%; ND is no data | human rhinovirus type 2 | 1 | organism-based format | Scientific Literature | ||
8. | ALA696046 | F | Antirhinovirus activity was assessed and the maximum testable concentration that causes no apparent effects on the cell monolayers was determined against HRV-2 virus in vitro; ND is no data. | human rhinovirus type 2 | 1 | organism-based format | Scientific Literature | ||
9. | ALA696047 | F | Antirhinovirus activity was assessed and the maximum testable concentration that causes no apparent effects on the cell monolayers was determined against HRV-2 virus in vitro. | human rhinovirus type 2 | 26 | organism-based format | Scientific Literature | ||
10. | ALA694423 | F | Anti-HRV activity against HRV-2 strain | human rhinovirus type 2 | 19 | organism-based format | Scientific Literature | ||
11. | ALA692495 | F | Broad spectrum antiviral activity was evaluated against HRV-2 | human rhinovirus2 | 1 | organism-based format | Scientific Literature | ||
12. | ALA858027 | F | In vitro anti-picornavirus activity against Rhinovirus type-2. | rhinovirus type 2 | 17 | organism-based format | Scientific Literature | ||
13. | ALA804252 | F | In vitro anti-picornavirus activity against Rhinovirus type-2; Not Active. | rhinovirus type 2 | 7 | organism-based format | Scientific Literature | ||
14. | ALA804253 | F | Evaluated for inhibitory activity against rhinovirus type 2 | rhinovirus type 2 | 14 | organism-based format | Scientific Literature | ||
15. | ALA878824 | F | In vitro anti-picornavirus activity against Rhinovirus type-2. | rhinovirus type-2 | 22 | organism-based format | Scientific Literature | ||
16. | ALA804257 | F | In vitro anti-picornavirus activity against Rhinovirus type-2; Not Active. | rhinovirus type-2 | 4 | organism-based format | Scientific Literature | ||
17. | ALA804258 | F | Minimum inhibitory concentration of compound in vitro against rhinovirus-2 | rhinovirus type-2 | 1 | organism-based format | Scientific Literature | ||
18. | ALA804913 | F | Minimum inhibitory concentration against human rhinovirus serotype 2 | human rhinovirus serotype 2 | 2 | organism-based format | Scientific Literature | ||
19. | ALA805082 | F | Minimum inhibitory concentration against human rhinovirus serotype 2 | human rhinovirus serotype 2 | 1 | organism-based format | Scientific Literature | ||
20. | ALA847821 | F | Expanded antirhinoviral activity against the rhinovirus serotype 2 | human rhinovirus type 2 | 1 | organism-based format | Scientific Literature |